SEC Form 4 · accession 0001437749-17-005536
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Randall Gilbertson
10% Owner
Period of report
Mar 27, 2017
Accepted (ET)
Mar 29, 2017 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 27, 2017 | A | 700,000 | $0.75 | A | 4,870,508 | D | |
| Common StockF1,F2 | Mar 27, 2017 | A | 280,000 | $0.75 | A | 280,000 | I | By Total Depth Foundation |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory Note (right to buy)F4,F3 | $1.125 | Mar 27, 2017 | D | 444,444 | D | Sep 14, 2015 | — | Common Stock | 444,444 | 0 | D |
| Convertible Promissory Note (right to buy)F4,F3 | $1.125 | Mar 27, 2017 | D | 177,776 | D | Sep 14, 2015 | — | Common Stock | 177,776 | 0 | I |
Explanation of responses
- F1Pursuant to an exchange agreement, on March 27, 2017 the recipient is entitled to the number of shares indicated on March 31, 2017.
- F2The shares will be issued in exchange for amounts due under a promissory note.
- F3The convertible promissory notes are scheduled to mature and become due and payable on December 27, 2018. The conversion right thereunder has no expiration date.
- F4Surrendered to issuer in exchange for shares of common stock pursuant to an exchange agreement.